[1] |
Wanf FS, Fan JG, Zhang Z, et al. The global burden of liver disease: The major impact of China[J]. Hepatology, 2014, 60(6):2099-2108.
doi: 10.1002/hep.v60.6
URL
|
[2] |
Lakkasani S, Maruboyina SP, Pantula S. A comparison study of association between non-alcoholic fatty liver disease and coronary artery disease by transient elastography and cardiac Catheterization[J]. Chest, 2020, 158(4S):A109-A109.
doi: 10.1016/j.chest.2020.08.134
URL
|
[3] |
Ichikawa K, Miyoshi T, Osawa K, et al. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: A prospective cohort study[J]. Cardiovasc Diabetol, 2021, 20(1):8.
doi: 10.1186/s12933-020-01192-4
pmid: 33413363
|
[4] |
Dobiásová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL))[J]. Clin Biochem, 2001, 34(7):583-588.
pmid: 11738396
|
[5] |
Cai GJ, Shi GW, Xue SL, et al. The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population[J]. Medicine, 2017, 96(37):e8058.
doi: 10.1097/MD.0000000000008058
URL
|
[6] |
杨晓, 谢勇, 徐日新, 等. 血浆致动脉硬化指数对早发冠心病的预测作用[J]. 临床心血管病杂志, 2020, 36(11):1000-1003.
|
[7] |
Dong BY, Mao YQ, Li ZY, et al. The value of the atherogenic index of plasma in non-obese people with non-alcoholic fatty liver disease: A secondary analysis based on a cross-sectional study[J]. Lipids Health Dis, 2020, 19(1):15080-873.
|
[8] |
Wang Q, Zheng DM, Liu J, et al. Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: A cross-sectional study[J]. Lipids Health Dis, 2018, 17(1):284.
doi: 10.1186/s12944-018-0932-0
URL
|
[9] |
中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志, 2018, 34(5):947-957.
|
[10] |
Rinella ME. Nonalcoholic fatty liver disease:a systematic review[J]. JAMA, 2015, 313(22):2263-2273.
doi: 10.1001/jama.2015.5370
pmid: 26057287
|
[11] |
Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis[J]. N Engl J Med, 2017, 377(21):2063-2073.
doi: 10.1056/NEJMra1503519
URL
|
[12] |
Zhang RN, Zheng RD, Mi YQ, et al. APOC3 rs2070666 is associated with the hepatic steatosis independently of PNPLA3 rs738409 in Chinese Han patients with nonalcoholic fatty liver diseases[J]. Dig Dis Sci, 2016, 61(8):2284-2293.
doi: 10.1007/s10620-016-4120-7
URL
|
[13] |
徐文静, 杨鸣宇, 何航宇. 肥胖冠心病患者非酒精性脂肪肝与Gensini评分之间的关系[J]. 中华肥胖与代谢病电子杂志, 2020, 6(1):47-50.
|
[14] |
王春亚, 柳伟伟, 赵攀. 非酒精性脂肪性肝病患者发生冠状动脉疾病的危险因素分析[J]. 疑难病杂志, 2017, 16(7):657-659+664.
|
[15] |
李国焕, 谢旭, 黄志霞, 等. 非酒精性脂肪性肝病的瞬时弹性成像技术和声辐射力脉冲成像技术的定量评价[J]. 临床荟萃, 2021, 36(6):535-539.
|